Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | HPGD | P15428 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9000066 | 0.93 | SMN1; SMN2 (0.40) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL12118354 | 0.92 | MAPT (0.35) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL16489114 | 0.90 | CA12 (0.36) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL18760512 | 0.89 | RAB9A (0.36) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL12093970 | 0.88 | ALDH1A1 (0.36) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL27957688 | 0.87 | SMN1; SMN2 (0.40) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL7120029 | 0.86 | SMN1; SMN2 (0.39) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL5539689 | 0.86 | TSHR (0.38) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| SCHEMBL20078883 | 0.84 | MAPT (0.34) | MEN1KMT2AL3MBTL1SMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL5547769 | 0.84 | SCN1A (0.36) | L3MBTL1SMN1; SMN2MAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1116988-A2 | Liquid crystal display with fluorescent front panel | Philips Patentverwaltung GmbH (DE) | 2001-07-18 | — | — | EP | claimed |
| US-20240159743-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-11013232-B2 | Hydrotesting and mothballing composition and method of using combination products for multifunctional water treatment | CLARIANT INTERNATIONAL LTD (CH) | 2021-05-25 | — | — | US | disclosed |
| EP-3610261-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | Juno Therapeutics, Inc. (US) | 2020-02-19 | — | — | EP | disclosed |
| WO-2018191723-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2018-10-18 | — | — | WO | disclosed |
| EP-3134355-B1 | HYDROTESTING AND MOTHBALLING COMPOSITION AND METHOD OF USING COMBINATION PRODUCTS FOR MULTIFUNCTIONAL WATER TREATMENT | CLARIANT INT LTD (CH) | 2018-05-16 | — | — | EP | disclosed |
| US-20170042145-A1 | Hydrotesting and Mothballing Composition and Method of using Combination Products for Multifunctional Water Treatment | CLARIANT INTERNATIONAL, LTD. (CH) | 2017-02-16 | — | — | US | disclosed |
| US-8993260-B2 | Fluorescence-based viability staining method using a membrane permeable flourescent dye and membrane impermeable fluorescence quencher | CHARLES RIVER LABORATORIES, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-8993260-B2 | Fluorescence-based viability staining method using a membrane permeable flourescent dye and membrane impermeable fluorescence quencher | CHARLES RIVER LABORATORIES, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-20130309686-A1 | VIABILITY STAINING METHOD | CHARLES RIVER LABORATORIES, INC. (US) | 2013-11-21 | — | — | US | disclosed |
| US-20100323298-A1 | Photosensitive composition, microfabrication method using the same, and microfabricated structure thereof | PARK JONG JIN | 2010-12-23 | — | — | US | disclosed |
| US-20100192312-A1 | POLYMERIC DYES | CIBA CORPORATION (US) | 2010-08-05 | — | — | US | disclosed |
| US-20100184934-A1 | POLYROTAXANE HAVING MAIN CHAIN BACKBONE ESSENTIALLY COMPOSED OF -Si-O- AND METHOD FOR PRODUCING THE SAME, AND CROSSLINKED POLYROTAXANE OBTAINED BY CROSSLINKING THE POLYROTAXANE AND METHOD FOR PRODUCING THE SAME | THE UNIVERSITY OF TOKYO (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20100184934-A1 | POLYROTAXANE HAVING MAIN CHAIN BACKBONE ESSENTIALLY COMPOSED OF -Si-O- AND METHOD FOR PRODUCING THE SAME, AND CROSSLINKED POLYROTAXANE OBTAINED BY CROSSLINKING THE POLYROTAXANE AND METHOD FOR PRODUCING THE SAME | THE UNIVERSITY OF TOKYO (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20100012284-A1 | METHOD FOR DETERMINING HYDROPHOBIC ORGANIC PARTICLES IN A PAPER STOCK | BASF SE (DE) | 2010-01-21 | — | — | US | disclosed |
| US-20080151227-A1 | Method for Determining a Sizing Agent Concentration, Particle Size and a Sizing Agent Particle Size Distribution in a Peper Pulp | BASF AKTIENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | disclosed |
| CN-1922672-A | Optical recording medium comprising molecules with hydrogen bonds | KONINKL PHILIPS ELECTRONICS NV (NL) | 2007-02-28 | — | — | CN | disclosed |
| EP-1116988-A2 | Liquid crystal display with fluorescent front panel | Philips Patentverwaltung GmbH (DE) | 2001-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100192312-A1 | POLYMERIC DYES | CBR1, CBR3, OXSR1 | MEN1 4345/4885KMT2A 2958/4885L3MBTL1 931/4885 |
| US-20170042145-A1 | Hydrotesting and Mothballing Composition and Method of using Combination Products for Multifunctional Water Treatment | DNMT3A, ACIN1, SRM | MEN1 3638/4885KMT2A 645/4885L3MBTL1 620/4885 |
| US-11013232-B2 | Hydrotesting and mothballing composition and method of using combination products for multifunctional water treatment | DNMT3A, ACIN1, SRM | MEN1 3638/4885KMT2A 645/4885L3MBTL1 620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.